Eliem Therapeutics Research and Development Expenses 2021-2024 | CLYM
Eliem Therapeutics research and development expenses from 2021 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Eliem Therapeutics Annual Research and Development Expenses
(Millions of US $) |
| 2023 |
$15 |
| 2022 |
$26 |
| 2021 |
$23 |
| 2020 |
$9 |
Eliem Therapeutics Quarterly Research and Development Expenses
(Millions of US $) |
| 2024-06-30 |
$1 |
| 2024-03-31 |
$1 |
| 2023-12-31 |
$3 |
| 2023-09-30 |
$3 |
| 2023-06-30 |
$4 |
| 2023-03-31 |
$6 |
| 2022-12-31 |
$5 |
| 2022-09-30 |
$4 |
| 2022-06-30 |
$9 |
| 2022-03-31 |
$8 |
| 2021-12-31 |
$7 |
| 2021-09-30 |
$6 |
| 2021-06-30 |
$6 |
| 2021-03-31 |
$5 |
| 2020-12-31 |
|
| 2020-09-30 |
$2 |
| 2020-06-30 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.342B |
$0.000B |
|
Eliem Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc. is based in SEATTLE, United Kingdom.
|
